Search Login Register
Bone Resorption
Summary
Description:
Bone loss due to osteoclastic activity.
Also Known As:
Bone Losses, Osteoclastic; Bone Resorptions; Loss, Osteoclastic Bone; Losses, Osteoclastic Bone; Osteoclastic Bone Losses Show All >>
Networked: 12154
relevant articles (385 outcomes,
1266 trials/studies)
for this Disease
Key Drugs and Agents for Bone Resorption
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Diphosphonates
:
50 outcomes 45 studies in 830 results
: IBA
-
Calcium
:
30 outcomes 91 studies in 1200 results
: IBA
-
Alendronate (Alendronate Sodium)
:
20 outcomes 49 studies in 259 results
:
FDA 18
Generic
-
pamidronate (APD)
:
20 outcomes 18 studies in 169 results
:
FDA 16
Generic
-
Biological Markers (Surrogate Marker)
:
15 outcomes 86 studies in 632 results
: IBA
-
deoxypyridinoline
:
15 outcomes 49 studies in 585 results
: IBA
-
Vitamin D
:
11 outcomes 26 studies in 256 results
:
FDA 10
Generic
-
Estrogens (Estrogen)
:
10 outcomes 29 studies in 415 results
:
FDA 1
-
risedronic acid (risedronate)
:
10 outcomes 19 studies in 90 results
:
FDA 4
Generic
-
Alkaline Phosphatase
:
9 outcomes 38 studies in 587 results
: IBA
Show All >>
Diseases Related to Bone Resorption
-
Osteoporosis
-
Neoplasm Metastasis (Metastasis)
-
Neoplasms (Cancer)
-
Hypercalcemia (Milk Alkali Syndrome)
-
Pain (Aches)
Show All >>
Key Therapies for Bone Resorption
Efficacy Chart >>
-
Ovariectomy (Oophorectomy)
:
6 outcomes 21 studies in 146 results
-
Transplants (Transplant)
:
6 outcomes 15 studies in 161 results
-
Injections
:
3 outcomes 4 studies in 38 results
-
Tooth Movement
:
2 outcomes 12 studies in 100 results
-
Arthroplasty
:
2 outcomes 8 studies in 63 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.